Mattioda C, Voena C, Ciardelli G, Mattu C
Cells. 2025; 14(1.
PMID: 39791739
PMC: 11720277.
DOI: 10.3390/cells14010038.
Kefallinou D, Grigoriou M, Boumpas D, Tserepi A
Bioengineering (Basel). 2024; 11(8).
PMID: 39199706
PMC: 11352072.
DOI: 10.3390/bioengineering11080748.
Olijnik A, Rodriguez-Romera A, Wong Z, Shen Y, Reyat J, Jooss N
Nat Protoc. 2024; 19(7):2117-2146.
PMID: 38532070
DOI: 10.1038/s41596-024-00971-7.
Barozzi D, Scielzo C
Hemasphere. 2023; 7(8):e932.
PMID: 37520775
PMC: 10378728.
DOI: 10.1097/HS9.0000000000000932.
de Janon A, Mantalaris A, Panoskaltsis N
J Immunol. 2023; 210(7):895-904.
PMID: 36947817
PMC: 7614371.
DOI: 10.4049/jimmunol.2200836.
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.
Khan A, Rodriguez-Romera A, Reyat J, Olijnik A, Colombo M, Wang G
Cancer Discov. 2022; 13(2):364-385.
PMID: 36351055
PMC: 9900323.
DOI: 10.1158/2159-8290.CD-22-0199.
Functionalized 3D scaffolds for engineering the hematopoietic niche.
Bruschi M, Vanzolini T, Sahu N, Balduini A, Magnani M, Fraternale A
Front Bioeng Biotechnol. 2022; 10:968086.
PMID: 36061428
PMC: 9428512.
DOI: 10.3389/fbioe.2022.968086.
Advancing Key Gaps in the Knowledge of Cryptic Infections Using Humanized Mouse Models and Organs-on-Chips.
Aparici Herraiz I, Caires H, Castillo-Fernandez O, Sima N, Mendez-Mora L, Risueno R
Front Cell Infect Microbiol. 2022; 12:920204.
PMID: 35873153
PMC: 9302440.
DOI: 10.3389/fcimb.2022.920204.
In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression.
Salazar-Terreros M, Vernot J
Int J Mol Sci. 2022; 23(13).
PMID: 35806354
PMC: 9266537.
DOI: 10.3390/ijms23137350.
Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells.
Mayer I, Hoelbl-Kovacic A, Sexl V, Doma E
Cancers (Basel). 2022; 14(7).
PMID: 35406494
PMC: 8996967.
DOI: 10.3390/cancers14071723.
The extracellular matrix of hematopoietic stem cell niches.
Lee-Thedieck C, Schertl P, Klein G
Adv Drug Deliv Rev. 2021; 181:114069.
PMID: 34838648
PMC: 8860232.
DOI: 10.1016/j.addr.2021.114069.
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment.
Franchi-Mendes T, Eduardo R, Domenici G, Brito C
Cancers (Basel). 2021; 13(18).
PMID: 34572836
PMC: 8468887.
DOI: 10.3390/cancers13184610.
Towards manufactured red blood cells for the treatment of inherited anemia.
Pellegrin S, Severn C, Toye A
Haematologica. 2021; 106(9):2304-2311.
PMID: 34042406
PMC: 8409035.
DOI: 10.3324/haematol.2020.268847.
Role of Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome.
Crippa S, Santi L, Berti M, De Ponti G, Bernardo M
Front Cell Dev Biol. 2021; 9:663316.
PMID: 34017834
PMC: 8129582.
DOI: 10.3389/fcell.2021.663316.
Comparative Analysis of Mesenchymal Stem Cell Cultivation in Fetal Calf Serum, Human Serum, and Platelet Lysate in 2D and 3D Systems.
Kirsch M, Rach J, Handke W, Seltsam A, Pepelanova I, Strauss S
Front Bioeng Biotechnol. 2021; 8:598389.
PMID: 33520956
PMC: 7844400.
DOI: 10.3389/fbioe.2020.598389.
Microfluidics and organ-on-a-chip technologies: A systematic review of the methods used to mimic bone marrow.
Santos Rosalem G, Gonzales Torres L, Casas E, Mathias F, Ruiz J, Carvalho M
PLoS One. 2020; 15(12):e0243840.
PMID: 33306749
PMC: 7732112.
DOI: 10.1371/journal.pone.0243840.
Energy metabolism: A newly emerging target of BMP signaling in bone homeostasis.
Yang J, Ueharu H, Mishina Y
Bone. 2020; 138:115467.
PMID: 32512164
PMC: 7423769.
DOI: 10.1016/j.bone.2020.115467.
Traditional and Advanced Cell Cultures in Hematopoietic Stem Cell Studies.
Ribeiro-Filho A, Levy D, Ruiz J, Mantovani M, Bydlowski S
Cells. 2019; 8(12).
PMID: 31842488
PMC: 6953118.
DOI: 10.3390/cells8121628.